A further difference between prostate cancer and brain tumours is that in the former, the C-terminal portion of GPR158 is translocated to the nucleus whilst we did not observe nuclear staining in CNS grey matter or in glioma cells using a specific anti-GPR158 C-terminal antibody. The gene discussed is GPR158; the disease is prostate cancer.